San Jose Mercury News, 01/11/16
--Bay Area biologist's gene-editing kit lets do-it-yourselfers play God at the kitchen table
This article discusses a DIY gene-editing kit that can be purchased by consumers for $120. David Relman and Hank Greely, with the Stanford Center for Biomedical Ethics, provide comment.
Fast Company, 01/13/16
--Due to this obscure loophole, some medical tests avoid oversight
The Food and Drug Administration does not currently regulate lab-developed tests, or medical tests that are designed and administered in a single laboratory, but it may expand its overview in coming months. Hank Greely, with the Stanford Center for Biomedical Ethics, is quoted here.
KQED (NPR), 01/15/16
--CRISPR patent war: Billions at stake for UC Berkeley
UC Berkeley and the Broad Institute are vying to hold the patent for CRISPR-Cas9, the powerful gene editing tool. Mildred Cho, professor of pediatrics and of medicine and associate director of the Stanford Center for Biomedical Ethics, is quoted here.